A Roadmap for the Success of Oncolytic Parvovirus-Based Anticancer Therapies.
Annu Rev Virol. 2020 Sep 29;7(1):537-557. doi: 10.1146/annurev-virology-012220-023606. Epub 2020 Jun 29.
Annu Rev Virol. 2020.
PMID: 32600158
Review.
Various strategies have been employed to improve the anticancer activities of oncolytic PVs, including development of second-generation parvoviruses with enhanced oncolytic and immunostimulatory activities and rational combination of PVs with other therapies. …
Various strategies have been employed to improve the anticancer activities of oncolytic PVs, including development of second-generati …